{"id":61903,"name":"NEURELIS, INC.","slug":"neurelis-inc","state":"CA","country":"United States of America","description":"Biopharmaceutical company specializing in treatments for neurological conditions.","totalSpending":80000,"filings":6,"yearlySpending":[{"year":2024,"income":30000},{"year":2025,"income":50000}],"issues":["HCR","MMM"],"firms":["ARNOLD & PORTER KAYE SCHOLER LLP"],"lobbyists":["SONJA NESBIT","BOBBY MCMILLIN","EUGENIA PIERSON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE"],"sampleDescriptions":["Policy issues related to federal regulation of the healthcare industry.","Policy issues related to federal regulation of the healthcare industry.","Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (H.R. 7383 / S. 1214, 118th Congress).","Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Retaining Access and Restoring Exclusivity (RARE) Act (118th, H.R. 7383 / S. 1214).","Policy issues related to federal regulation of the healthcare industry and rare diseases, including the Give Kids a Chance Act (119th, H.R. 1262 / S. 932) and Retaining Access and Restoring Exclusivit"],"years":[2024,2025]}